New approaches to cure and even prevent Alzheimer's disease are being pursued by several drug firms. Neurochem announced recruitment of patients for a trial of its drug Alzhemed, designed to prevent formation of the plaques suspected to be responsible for Alzheimer's, while Lilly and Wyeth are working along similar lines and other researchers are conducting large trials of existing drugs, vitamins and herbs.

Related Summaries